BJOG : an international journal of obstetrics and gynaecology
-
Randomized Controlled Trial Multicenter Study
Intramuscular oxytocin versus Syntometrine® versus carbetocin for prevention of primary postpartum haemorrhage after vaginal birth: a randomised double-blinded clinical trial of effectiveness, side effects and quality of life.
To compare intramuscular oxytocin, Syntometrine® and carbetocin for prevention of postpartum haemorrhage after vaginal birth. ⋯ IM carbetocin does not reduce additional uterotonic use compared with IM Syntometrine or oxytocin.
-
Randomized Controlled Trial Multicenter Study
An economic evaluation of tranexamic acid to prevent postpartum haemorrhage in women with vaginal delivery: the randomised controlled TRAAP trial.
To estimate the cost-effectiveness of tranexamic acid (TXA) use to prevent postpartum haemorrhage. ⋯ Tranexamic acid at vaginal delivery reduces both costs and bleeding events 3 times out of 4.
-
Multicenter Study
Obstetric admissions to intensive care units in Australia and New Zealand: a registry-based cohort study.
Describe the epidemiology of obstetric patients admitted to an Intensive Care Unit (ICU). ⋯ Obstetric patients in Australia/New Zealand ICUs have a short length of ICU stay and low mortality.
-
Randomized Controlled Trial Multicenter Study Comparative Study
Vaginoscopy Against Standard Treatment: a randomised controlled trial.
To evaluate whether vaginoscopy or standard hysteroscopy was more successful in the outpatient setting. ⋯ Vaginoscopy is quicker to perform, less painful, and more successful than standard hysteroscopy.
-
Multicenter Study
Asparaginase-like protein 1 expression in curettage independently predicts lymph node metastasis in endometrial carcinoma: a multicentre study.
Correct preoperative identification of high-risk patients is important to optimise surgical treatment and improve survival. We wanted to explore if asparaginase-like protein 1 (ASRGL1) expression in curettage could predict lymph node metastases and poor outcome, potentially improving preoperative risk stratification. ⋯ Low ASRGL1 expression in curettage predicts lymph node metastasis and poor survival in endometrial carcinoma.